Market Currents
Avanir Pharmaceuticals (AVNR): FQ1 EPS loss of $0.09 misses by $0.01. Revenue of $16.5M (+130%...
-
Thursday, February 7, 4:18 PM ETAvanir Pharmaceuticals (AVNR): FQ1 EPS loss of $0.09 misses by $0.01. Revenue of $16.5M (+130% Y/Y) in line. (PR).
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
